The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer.
 
Shao Zhimin
No Relationships to Disclose
 
Junjie Li
No Relationships to Disclose
 
Da Pang
No Relationships to Disclose
 
Changqing Wang
No Relationships to Disclose
 
Jun Jiang
No Relationships to Disclose
 
Suisheng Yang
No Relationships to Disclose
 
Yunjiang Liu
No Relationships to Disclose
 
Pei Fen Fu
No Relationships to Disclose
 
Yuan Sheng
No Relationships to Disclose
 
Guojun Zhang
No Relationships to Disclose
 
Liya Cao
No Relationships to Disclose
 
Qi He
No Relationships to Disclose
 
Shude Cui
No Relationships to Disclose
 
Xijing Wang
No Relationships to Disclose
 
Guosheng Ren
No Relationships to Disclose
 
Xinzheng Li
No Relationships to Disclose
 
Shiyou Yu
No Relationships to Disclose
 
Pengxi Liu
No Relationships to Disclose
 
Binghe Xu
No Relationships to Disclose
 
Xi-Chun Hu
No Relationships to Disclose